Discussion of a case of vitiligo

Photodermatology Photoimmunology and Photomedicine

Volumn 15, Issue 1, 1999, Pages 41-44

  Lerner, Michael R ^a   Fitzpatrick, T B ^b   Halder, R M ^c   Hawk, J L M ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOWARD UNIVERSITY   (United States)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Monobenzylether of hydroquinone; PUVA therapy; Topical codicosteroids; UVB radiation; Vitiligo

Indexed keywords

CORTICOSTEROID; HYDROQUINONE; PSORALEN;

ARTICLE; CASE REPORT; CHILD; DEPIGMENTATION; HUMAN; MALE; PRIORITY JOURNAL; PUVA; SKIN PIGMENTATION; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VITILIGO;

EID: 0032934498     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.1999.tb00054.x     Document Type: Article

References (7)

1. Halder RM. Childhood vitiligo. Clin Dermatol 1997: 15: 899-906.
2. Grimes PE, Kelly AP. Management of vitiligo in children. Pediatr Dermatol 1986: 3: 498-510.
3. Nordlund JJ, Halder RM, Grimes PE. Management of vitiligo. Dermatol Clin 1993: 11: 27-33.
4. Nordlund JJ, Halder RM, Grimes PE et al. Guidelines of care for vitiligo. J Am Acad Dermatol 1996: 35: 620-626.
5. Grimes PE, Minus HR, Chakrabarti SG et al. Determination of optimal topical photochemotherapy for vitiligo. J Am Acad Dermatol 1982: 7: 771-778.
6. Halder RM. Topical PUVA therapy for vitiligo. Dermatol Nursing 1991: 3: 178-180.
7. Halder RM, Battle EF, Smith EM. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. Arch Dermatol 1995: 131: 734-735.